4D Molecular Therapeutics (FDMT) Research & Development (2020 - 2025)
Historic Research & Development for 4D Molecular Therapeutics (FDMT) over the last 6 years, with Q3 2025 value amounting to $49.4 million.
- 4D Molecular Therapeutics' Research & Development rose 2846.38% to $49.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $181.2 million, marking a year-over-year increase of 4582.43%. This contributed to the annual value of $141.3 million for FY2024, which is 4552.5% up from last year.
- According to the latest figures from Q3 2025, 4D Molecular Therapeutics' Research & Development is $49.4 million, which was up 2846.38% from $48.0 million recorded in Q2 2025.
- In the past 5 years, 4D Molecular Therapeutics' Research & Development ranged from a high of $49.4 million in Q3 2025 and a low of $12.8 million during Q1 2021
- Its 5-year average for Research & Development is $27.3 million, with a median of $23.6 million in 2023.
- In the last 5 years, 4D Molecular Therapeutics' Research & Development plummeted by 316.16% in 2021 and then skyrocketed by 6554.1% in 2024.
- Quarter analysis of 5 years shows 4D Molecular Therapeutics' Research & Development stood at $17.5 million in 2021, then grew by 22.66% to $21.5 million in 2022, then increased by 21.06% to $26.0 million in 2023, then surged by 65.54% to $43.1 million in 2024, then increased by 14.74% to $49.4 million in 2025.
- Its last three reported values are $49.4 million in Q3 2025, $48.0 million for Q2 2025, and $40.7 million during Q1 2025.